about
Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposureTwo weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics.The role of taurine in diabetes and the development of diabetic complications.Mechanisms of insulin secretion in malnutrition: modulation by amino acids in rodent models.Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review.Potential role of taurine in the prevention of diabetes and metabolic syndrome.Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets.An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin.Glutamate ingestion and its effects at rest and during exercise in humans.Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus.Effect of fishmeal replacement by soy protein concentrate with taurine supplementation on growth performance, hematological and biochemical status, and liver histology of totoaba juveniles (Totoaba macdonaldi).Taurine and pioglitazone attenuate diabetes-induced testicular damage by abrogation of oxidative stress and up-regulation of the pituitary-gonadal axis.Taurine depresses cardiac contractility and enhances systemic heart glucose utilization in the cuttlefish, Sepia officinalis.The Effect on Blood Biochemical Factors of a ICR-Mice in a High-Fat Diet with Taurine 20.
P2860
Q28387506-53B69AF1-2D60-46AF-9998-6BDAC376B16DQ33644126-50C197AF-2DF6-4010-AF98-B9123AF25FA0Q34465081-7BB53D4C-5339-4EFB-A6F2-E7DF7E1280E4Q37780136-B34FA074-236C-4583-89CB-9388C7DDDFE6Q38038803-DE6B1135-1AF0-49C9-A6B6-F79F14BE313FQ38066067-634C5064-8022-40E1-8EF9-108EACE9402CQ38299247-3A8679FE-B0DF-477D-A903-C1A1407F5C2DQ39551344-A339C897-0577-4AE7-A1F2-C9E29BCC0DDDQ42512666-101B8403-65F0-47CB-B500-19E70CF50AFCQ44138613-9F809E4C-8EA1-4E91-867D-1C6BE3C0E21DQ44822479-4AAA1FB7-401B-427A-B075-8BF4BF2D9595Q45218808-71B856C0-33FB-43EE-99AD-2ADC8F47DDE2Q52139481-200569B3-BBE3-42A4-B214-1DDDD6151FD1Q53257114-5FCD45D0-C95F-4510-927C-FF8D43880F18Q54310319-9939D80F-2359-440B-B654-672F85DC3EA4
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Taurine binding to the purified insulin receptor.
@en
Taurine binding to the purified insulin receptor.
@nl
type
label
Taurine binding to the purified insulin receptor.
@en
Taurine binding to the purified insulin receptor.
@nl
prefLabel
Taurine binding to the purified insulin receptor.
@en
Taurine binding to the purified insulin receptor.
@nl
P1476
Taurine binding to the purified insulin receptor.
@en
P2093
Kulakowski EC
P304
P356
10.1016/0006-2952(88)90411-X
P407
P577
1988-10-01T00:00:00Z